Načítá se...
Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen
Fatal interstitial lung disease (ILD) is one of the rare side effects of Panitumumab. Both fatal and non-fatal ILD have been reported mainly in the Japanese population. We report a case of a nonsmoking Caucasian man with the diagnosis of metastatic rectal cancer (K-RAS wild-type) who developed fatal...
Uloženo v:
| Vydáno v: | Ecancermedicalscience |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cancer Intelligence
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027982/ https://ncbi.nlm.nih.gov/pubmed/30034518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.841 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|